期刊文献+

结直肠癌根治术后区域动脉灌注化疗的临床观察 被引量:5

Appraisal of Transcatheter Arterial Infusion(TAI) Chemotherapy after Colorectal Carcinoma Radical Resection
暂未订购
导出
摘要 目的:探讨大肠癌根治术后介入化疗对癌复发和预后的影响。方法:大肠癌根治术后一个月,根据癌灶位置,经股动脉插管进入肝总动脉、肠系膜上或肠系膜下动脉、髂内动脉,定期灌注抗癌药物。临床应用51例,平均40天进行一次,4~6次为一疗程,观察癌复发和生存时间(观察组)。并对大肠癌根治术后49例全身化疗患者进行比较分析(对照组)。结果:观察组1、3、5年复发率为7.8%(4/51)、23.5%(12/51)、33.3%(17/51);生存率98.0%(50/51)、86.3%(44/51)、72.4%(37/51)。对照组1、3、5年复发率为16.3%(8/49)、38.8%(19/49)、75.5%(37/49);生存率87.8%(45/49)、63.3%(31/49)、43.0%(21/49)。两组比较差异具有显著性。结论:大肠癌根治术后区域动脉灌注化疗是预防癌复发和改善预后的有效手段。 Objective:To evalua te the e ffect of postoperative TAI for prevention and treat-ment of colorectal carcin oma recurrence after radical resection.Methods:In51colorectal cancer patien ts received TAI with seldinger technique,the pipe was inserted into the arteri es that supply tumour with nutrition.Through the pipe,5-Fu,ADM,EPI and C BP were infused into the arter-ies every average40days.Results:The treatmen t group5-year survival rate was72.5%re-spectively while that in the oth er group was43%.The differences between the2groups of patients were statist ically significant (P<0.01).Conclusion:Postoperative TAI possess obvio us effect of prevention of colorectal cancer recurrence.
机构地区 焦作市人民医院
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第1期37-39,共3页 Chinese Journal of Clinical Oncology
关键词 根治术 直肠肿瘤 化疗 区域动脉灌注 肿瘤复发 结肠肿瘤 Colorectal c arcinoma Chemotherapy Transcatheter arterial infusion Recurrence carcinoma
  • 相关文献

参考文献4

二级参考文献95

共引文献64

同被引文献31

  • 1路平,庞葵,王舒宝,陈峻青,徐惠绵.复发大肠癌再手术的临床分析[J].中国实用外科杂志,2004,24(7):409-411. 被引量:13
  • 2余成仿,王吉甫.大肠癌术后复发和转移的临床研究─—附82例分析[J].中国普通外科杂志,1994,3(2):79-82. 被引量:4
  • 3晏仲舒.对待腹膜肿瘤种植转移的新概念[J].中国普通外科杂志,2006,15(10):801-802. 被引量:9
  • 4Hermreck AS, Thomas CY, Friesen SR,et al. Importance of pathologic staging in the surgical management of adenocarcinoma of the exocine pancreas[ J]. Am J Surg, 1974,127 (4) :653 - 654.
  • 5Cascinu S, Silia RR, Barni S, et al. A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)[ J ]. Br J Cancer, 1999,80(12): 1595 - 1598.
  • 6Manuel H, Uaniel C, Luis P, et al. Phase Ⅰ - Ⅱ study of gemcitabine and fluoronracil as a continuous infusion in patients with pancreatic cancer [J]. J Clin Oncol, 1999, 17(5):585- 592.
  • 7Clark JW, Gligksman AS, Wanebo HJ, et al. Systemic and adjurant therapy for patients with pancreatic cancinoma[ J]. Cancer, 1996,78 (3) :688- 693.
  • 8Louvel C,De Gramonf A,Demuynck B,et al.High-does folinic acid,5 -fluorour acid bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer[J].Ann,1997,2:779
  • 9CHoiti MA,sitzmann JV,Tiburi MF,et al.Trends in longterm survival following liver resection for hepatic.colorectal metastasis[J].Ann Surg,2002,235 (6):759-766.
  • 10Delaunoit T,Alberts SR,Sargent DJ,et al.Chemotherapy permits resection of metastatic colorectal carcer:experience from intergroup N9741[J].Ann Oncol,2005,16 (3):425-429.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部